EDA Logo
Sorry, this website does not support this browser

Regulatory Guidelines

Regulatory Guidelines for the central Administration For Pharmaceutical products

Regulatory Guidelines for the General Administration Of Pharmaceutical products registration

guideline for Bioavailability and Bioequivalence studies:

Type Issue date description Issue No.
Guide line 06-2026 Egyptian Guideline for Conducting Bioequivalence
Studies for Marketing Authorization of Generic
04

guideline for Naming and mockup of Human Pharmaceutical product  

Type Issue date description Issue No.
Guide line May-2023 Guidelines on mock-up Design of Human Pharmaceutical Products 2023  03
Guide line Apr-2024 GUIDELINES ON Naming of Human Pharmaceutical Products 04

guideline For variation of Human Pharmaceutical product  

Type Issue date description Issue No.
Guide line Dec-2025 Guidelines For Human Pharmaceuticals Variations  06

guideline For Registration Of Human pharmaceutical products

Type Issue date description Issue No.
Guide line OCT-2022 Good Review Practice Guideline   
Guide line Mar-2023

Egyptian Guidelines on CTD Quality Module For Human Pharmaceuticals 

02

Guide line Mar-2023 Guidelines on Assessment of safety & efficacy that impact withdrawal,
suspension or revocation of registration procedures or marketing authorization license-
02
Guide line April-2023 Guidelines on Emergency Use Approval 04
Guide line Dec-2023 Guideline On Dossier Requirements of Human Pharmaceutical Products for Registration and Re-registration 04
Guide line Aug-2024 Guidelines on Reliance Practices During Registration of Medicinal Products          04
Guide line Apr-2025
 01
Guide line Jul-2025 01
Guide line Sep-2025 02
Guide line oct-2025 Regulatory Guideline on Organizing the Rules and Procedures of Registration of Human Pharmaceutical Products in Accordance with the Different Cases Based on Egyptian Drug Authority Chairman Decree No. (450) of 2023
05
Guide line Oct-2025 Regulatory Guide on The Registration of Synthetic Peptides Human Pharmaceutical Products that refer to a Reference Peptide Product of rDNA Origin
04
Guide line 12- 2025

Organizing the Rules and Procedures of the Reregistration of Human pharmaceutical Products in
Accordance with the EDA Chairman Decree No. (150) of
2022

Arabic version

07
Guide line 12-2025 Guidelines for Nitrosamine Impurities in Drug substances and pharmaceutical drug Products 01

Regulatory Guidelines for the General Administration Of Veterinary Pharmaceuticals 

Type Issue date description Issue No.
Guide line 10/2023 Guidelines on Procedures for Re-registering Veterinary Pharmaceuticals According to the Chairman of Egyptian Drug Authority’s Decision No. (434) of 2022

02

Guide line 02/2024

Guideline on Veterinary Pharmaceuticals Variations

01

Guide line 03/2024 Guideline of Registering Veterinary Pharmaceuticals Imported from
Reference Countries According to the Fast Track Registration System

03

Guide line 10/2024 Guidelines on Naming of Veterinary Pharmaceuticals   05
Guide line 08/2025 Guidelines on Registration Procedures of Veterinary Pharmaceuticals According to the Chairman of Egyptian Drug Authority’s Decision No. 625 Year 2024 02
Guide line 01/2026 Egyptian Guidelines for Conducting Bioequivalence Studies for Generic Veterinary Medicinal Products 01
Guide line 03/2026 Guidelines for the update of the mechanism of addition/ transfer of manufacturing site of registered local human and veterinary medicinal products 03

Regulatory Guidelines for the General Administration For Herbal Medicinal products registration

Type Issue date description Issue No.
Guide line Aug-21 Egyptian Guidelines for Registration of Herbal Medicines 02
Guide line Sep-21 Executive Procedures of Reviewing the Cards of
Herbal Medicine Products
01
Guide line Sep-21 Executive Procedures of Reviewing the Names of
Herbal Medicine Products
01
Guide line Nov-2025

Executive Procedures of the Decree of Egyptian Drug Authority's President No. (572) of 2022 on Regulating Procedures of Registration/Re-registration of the Complementary Medical Products

 
02
Guide line Nov-2025

Executive Procedures for Regulating Registration/Re-registration
Procedures for Herbal Pharmaceutical Products
acc. to Decision of Technical Committee for Drug Control at 23/01/2020Year 2022

 
04

Regulatory Guidelines for the General Administration For Cosmetic products registration

Type Issue date description Issue No.
Guide line 6-Mar-2022 Regulatory Guide for Cosmetics Notification 01
Guide line 14-Apr-2025 Claims Guide for Cosmetics Notification 05
Guide line 04-Aug-2025 Documents Required for Variations of Cosmetic Products 01

Regulatory Guidelines for the General Administration Of Biocides registration

Type Issue date description Issue No.
Guide line Feb-2025 Regulatory and Guidance Guideline and Business Rules for
Antiseptics/Disinfectants Registration
 03
Guide line Feb-2025 Regulatory Guidelines and Work Rules for the Registration of Pesticides 03

 

Copy Rights @ EDA 2021